Aging and infectious diseases in the developing world

Clinical Infectious Diseases

Volumn 39, Issue 1, 2004, Pages 83-91

  Gavazzi, Gaëtan ^a,b   Herrmann, Francois ^a   Krause, Karl Heinz ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Biology of Aging Laboratory   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; AGING; CLINICAL FEATURE; DEMOGRAPHY; DEVELOPING COUNTRY; DIARRHEA; ECONOMIC ASPECT; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFLUENZA; LEISHMANIASIS; MALARIA; MALNUTRITION; NUTRITIONAL STATUS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SOCIOECONOMICS; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGED; AGING; COMMUNICABLE DISEASES; DEMOGRAPHY; DEVELOPING COUNTRIES; DIARRHEA; DRUG RESISTANCE, MICROBIAL; HELMINTHIASIS; HUMANS; INFLUENZA, HUMAN; LEISHMANIASIS; MALARIA; NUTRITION PHYSIOLOGY; PUBLIC HEALTH; TUBERCULOSIS;

EID: 3042752280     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421559     Document Type: Review

References (105)

1. Yoshikawa TT. Perspective: aging and infectious diseases: past, present, and future. J Infect Dis 1997; 176:1053-7.
2. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 2: 659-66.
3. High KP. Infection in an ageing world. Lancet Infect Dis 2002; 2:655.
4. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World population prospects: the 2002 revision and world urbanization prospects. New York: United Nations, 2002.
5. Kinsella K. Demographic aspects. In: Ebrahim S, Kalache A, eds. Epidemiology in old age. Vol. 1. London: BMJ Publishing Group, 1996:32-40.
6. Lloyd-Sherlock P. Population ageing in developed and developing regions: implications for health policy. Soc Sci Med 2000; 51:887-95.
7. Kalache A. Ageing worldwide. In: Ebrahim S, Kalache A, eds. Epidemiology in old age. Vol. 1. London: BMJ Publishing Group, 1996: 22-31.
8. Jamison DT, Mosley WH. Disease control priorities in developing countries: health policy responses to epidemiological change. Am J Public Health 1991; 81:15-22.
9. Peters DH, Rao KS, Fryatt R. Lumping and splitting: the health policy agenda in India. Health Policy Plan 2003; 18:249-60.
10. Omran AR. Epidemiologic transition in the United States: the health factor in population change. Popul Bull 1977; 32:1-42.
11. World Health Organization. The world health report 2002. Geneva: World Health Organization, 2002
12. Janssens JP, Herrmann F, MacGee W, Michel JP. Cause of death in older patients with anatomo-pathological evidence of chronic bronchitis or emphysema: a case-control study based on autopsy findings. J Am Geriatr Soc 2001; 49:571-6.
13. Gjorup IE, Ronn A. Malaria in elderly nonimmune travelers. J Travel Med 2002; 9:91-3.
14. Muhlberger N, Jelinek T, Behrens RH, et al. Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis 2003; 36:990-5.
15. Baird JK, Masbar S, Basri H, Tirtokusumo S, Subianto B, Hoffman SL. Age-dependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. J Infect Dis 1998; 178:592-5.
16. Schwartz E, Sadetzki S, Murad H, Raveh D. Age as a risk factor for severe Plasmodium falciparum malaria in nonimmune patients. Clin Infect Dis 2001; 33:1774-7.
17. Soe S, Druilhe P. The implications of naturally acquired immunity to malaria in Southeast Asia. Trends Parasitol 2002; 18:8-10.
18. Kleinschmidt I, Sharp B. Patterns in age-specific malaria incidence in a population exposed to low levels of malaria transmission intensity. Trop Med Int Health 2001; 6:986-91.
19. Baird JK. Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol 1998; 92:367-90.
20. N'Diaye CL. Paludisme: aspects épidémiologiques, cliniques et évolutifs chez la personne âgée à Dakar. Infectious Disease Departement. Dakar: Cheikh Anta Diop University, 2003:96.
21. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000; 31:578-85.
22. Tran TH, Day NP, Nguyen HP, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996; 335:76-83.
23. World Health Organization. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1):S1-90.
24. Ashford RW. The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol 2000; 30:1269-81.
25. Kubar J, Marty P, Lelievre A, et al. Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS 1998; 12:2147-53.
26. Morales MA, Cruz I, Rubio JM, et al. Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1. J Infect Dis 2002; 185:1533-7.
27. Hernandez-Perez J, Yebra-Bango M, Jimenez-Martinez E, et al. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis 1999; 29:918-21.
28. EL-Safi SH, Bucheton B, Kheir MM, et al. Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996-1997). Microbes Infect 2002; 4: 1439-47.
29. Werneck GL, Rodrigues L, Santos MV, et al. The burden of Leishmania chagasi infection during an urban outbreak of visceral leishmaniasis in Brazil. Acta Trop 2002; 83:13-8.
30. McCarthy J, Moore TA. Emerging helminth zoonoses. Int J Parasitol 2000; 30:1351-60.
31. Liu LX, Weller PF. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am 1993; 7:655-82.
32. Bethony J, Chen J, Lin S, et al. Emerging patterns of hookworm infection: influence of aging on the intensity of Necator infection in Hainan Province, People's Republic of China. Clin Infect Dis 2002; 35:1336-44.
33. Chiao EY, Ries KM, Sande MA. AIDS and the elderly. Clin Infect Dis 1999; 28:740-5.
34. Shah SS, McGowan IP, Smith C, Blum S, Klein RS. Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis 2002; 35:1238-43.
35. Knodel J, Watkins S, VanLandingham M. AIDS and older persons: an international perspective. J Acquir Immune Defic Syndr 2003; 33: S153-S165.
36. Ibara JR, Itoua C, Gathse A, et al. Acquired immunodeficiency syndrome in elderly persons in a tropical zone: apropos of 175 cases in the Congo [in French]. Bull Soc Pathol Exot 2002; 95:100-2.
37. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis 2003; 36:79-85.
38. Nyambi P, Zekeng L, Kenfack H, et al. HIV infection in rural villages of Cameroon. J Acquir Immune Defic Syndr 2002; 31:506-13.
39. Mtei LN, Pallangyo KP. HIV infection in elderly medical patients. East Afr Med J 2001; 78:144-7.
40. Holmgren B, da Silva Z, Larsen O, Vastrup P, Andersson S, Aaby P. Dual infections with HIV-1, HIV-2 and HTLV-I are more common in older women than in men in Guinea-Bissau. AIDS 2003; 17:241-53.
41. Yerly S, Quadri R, Negro F, et al. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis 2001; 184:369-72.
42. Crampin AC, Floyd S, Glynn JR, et al. Long-term follow-up of HIV-positive and HIV-negative individuals in rural Malawi. AIDS 2002; 16:1545-50.
43. Jones N, Huebner R, Khoosal M, Crewe-Brown H, Klugman K. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS 1998; 12:2177-84.
44. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 2001; 15:899-906.
45. Corbett EL, Steketee RW, ter Kuile FO, Latif AS, Kamali A, Hayes RJ. HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 2002; 359:2177-87.
46. McDonald LC, Archibald LK, Rheanpumikankit S, et al. Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. Lancet 1999; 354:1159-63.
47. Pintado V, Lopez-Velez R. HIV-associated visceral leishmaniasis. Clin Microbiol Infect 2001; 7:291-300.
48. Knodel J, VanLandingham M. The impact of the AIDS epidemic on older persons. AIDS 2002; 16(Suppl 4):S77-83.
49. World Health Organization. Impact of AIDS on older people in Africa: Zimbabwe case study. Geneva: World Health Organization, 2002.
50. Wilson AO, Adamchak DJ. The grandmothers' disease - the impact of AIDS on Africa's older women. Age Ageing 2001; 30:8-10.
51. Knodel J, VanLandingham M, Saengtienchai C, Im-em W. Older people and AIDS: quantitative evidence of the impact in Thailand. Soc Sci Med 2001; 52:1313-27.
52. World Health Organization. World Health Organization Report 2003: global tuberculosis control surveillance. WHO/CDS/TB/2003.316. Geneva: World Health Organization, 2003.
53. Raviglione MC. The TB epidemic from 1992 to 2002 [review]. Tuberculosis (Edinb) 2003; 83:4-14.
54. Janssens JP, Zellweger JP. Clinical epidemiology and treatment of tuberculosis in elderly patients [in German]. Schweiz Med Wochenschr 1999; 129:80-9.
55. Rajagopalan S. Tuberculosis and aging: a global health problem. Clin Infect Dis 2001; 33:1034-9.
56. Rizvi N, Shah RH, Inayat N, Hussain N. Differences in clinical presentation of pulmonary tuberculosis in association with age. J Pak Med Assoc 2003; 53:321-4.
57. Arora VK, Singla N, Sarin R. Profile of geriatric patients under DOTS in Revised National Tuberculosis Control Programme. Indian J Chest Dis Allied Sci 2003; 45:231-5.
58. Carvalho AC, Nunes ZB, Martins M, et al. Clinical presentation and survival of smear-positive pulmonary tuberculosis patients of a university general hospital in a developing country. Mem Inst Oswaldo Cruz 2002; 97:1225-30.
59. Liaw YS, Yang PC, Yu CJ, et al. Clinical spectrum of tuberculosis in older patients. J Am Geriatr Soc 1995; 43:256-60.
60. Harries AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FM. High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis 2001; 5:1000-5.
61. Farthing MJ. Diarrhoea: a significant worldwide problem. Int J Antimicrob Agents 2000; 14:65-9.
62. Chai JY, Kim NY, Guk SM, et al. High prevalence and seasonality of cryptosporidiosis in a small rural village occupied predominantly by aged people in the Republic of Korea. Am J Trop Med Hyg 2001; 65: 518-22.
63. Coker AO, Isokpehi RD, Thomas BN, Amisu KO, Obi CL. Human campylobacteriosis in developing countries. Emerg Infect Dis 2002; 8:237-44.
64. Isenbarger DW, Hoge CW, Srijan A, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis 2002; 8:175-80.
65. Gambhir IS, Jaiswal JP, Nath G. Significance of Cryptosporidium as an aetiology of acute infectious diarrhoea in elderly Indians. Trop Med Int Health 2003; 8:415-9.
66. Ba AB. Pathologie infectieuse du sujet àgé: à propos de 773 cas dans le CHU de Dakar de 1979 à 1988. Infectious disease departement. Dakar: Cheikh Anta Diop University, 1989:76.
67. Besselaar TG, Schoub BD, Blackburn NK. Impact of the introduction of A/Sydney/5/97 H3N2 influenza virus into South Africa. J Med Virol 1999; 59:561-8.
68. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; 17:53-10.
69. Retailliau HF, Gale JL, Beasley RP, Hattwick MA. Excess mortality and influenza surveillance in Taiwan. Int J Epidemiol 1978; 7:223-9.
70. Stamboulian D, Bonvehi PE, Nacinovich FM, Ruttimann RW. Immunization against influenza in the elderly: the Argentinian experience, 1993-1997. Vaccine 1999; 17(Suppl 1):S53-6.
71. Gutierrez EB, Li HY, Santos AC, Lopes MH. Effectiveness of influenza vaccination in elderly outpatients in Sao Paulo city, Brazil. Rev Inst Med Trop Sao Paulo 2001; 43:317-20.
72. Jianping H, Xin F, Changshun L, et al. Assessment of effectiveness of Vaxigrip. Vaccine 1999; 17(Suppl 1):S57-8.
73. Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 2000; 30:931-3.
74. Karstaedt AS, Khoosal M, Crewe-Brown HH. Pneumococcal bacteremia in adults in Soweto, South Africa, during the course of a decade. Clin Infect Dis 2001; 33:610-4.
75. Fedson DS, Scott JA, Scott G. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 1999; 17(Suppl 1):S11-8.
76. Saldias F, Mardonez JM, Marchesse M, Viviani P, Farias G, Diaz A. Community-acquired pneumonia in hospitalized adult patients: clinical presentation and prognostic factors [in Spanish]. Rev Med Chil 2002; 130:1373-82.
77. Scott JA, Hall AJ, Muyodi C, et al. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet 2000; 355:1225-30.
78. Dey AB, Nagarkar KM, Kumar V. Clinical presentation and predictors of outcome in adult patients with community-acquired pneumonia. Natl Med J India 1997; 10:169-72.
79. Dioum M. Méningites purulentes du sujet àgé: à propos de 63 cas hospitalisé au CHU de Dakar de 1980 à 1989. Infectious diseases departement. Dakar: Cheikh Anta Diop University, 1990:81.
80. Ba AB. Pathologie infectieuse du sujet àgé: à propos de 773 cas dans le CU de Dakar de 1979 à 1988. Infectious disease departement. Dakar: Cheikh Anta Diop University, 1989:76.
81. Emori TG, Banerjee SN, Culver DH, et al. Nosocomial infections in elderly patients in the United States, 1986-1990. National Nosocomial Infections Surveillance System. Am J Med 1991; 91:289S-93S.
82. Strausbaugh LJ. Emerging health care-associated infections in the geriatric population. Emerg Infect Dis 2001; 7:268-71.
83. Sadoyama G, Gontijo Filho PP. Risk factors for methicillin resistant and sensitive Staphylococcus aureus infection in a Brazilian university hospital. Braz J Infect Dis 2000; 4:135-43.
84. Wang X, Zhou H, Wang X, et al. A study on nosocomial infection among inpatients in Beijing Hospital for elderly [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2001; 22:212-4.
85. Kesah C, Ben Redjeb S, Odugbemi TO, et al. Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin Microbiol Infect 2003; 9:153-6.
86. Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis 1999; 5:18-27.
87. Berner YN, Lang R, Chowers MY. Outcome of West Nile fever in older adults. J Am Geriatr Soc 2002; 50:1844-6.
88. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344:1807-14.
89. Garcia-Rivera EJ, Rigau-Perez JG. Dengue severity in the elderly in Puerto Rico. Rev Panam Salud Publica 2003; 13:362-8.
90. High KP. Nutritional strategies to boost immunity and prevent infection in elderly individuals. Clin Infect Dis 2001; 33:1892-900.
91. Vellas B, Lauque S, Andrieu S, et al. Nutrition assessment in the elderly. Curr Opin Clin Nutr Metab Care 2001; 4:5-8.
92. Charlton KE, Rose D. Nutrition among older adults in Africa: the situation at the beginning of the mulenium. J Nutr 2001; 131: 2424S-8S.
93. Kyle UG, Unger P, Mensi N, Genton L, Pichard C. Nutrition status in patients younger and older than 60 y at hospital admission: a controlled population study in 995 subjects. Nutrition 2002; 18:463-9.
94. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS. How many child deaths can we prevent this year? Lancet 2003; 362:65-71.
95. Tucker KL, Buranapin S. Nutrition and aging in developing countries. J Nutr 2001; 131:2417S-23S.
96. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ 1998; 317:647-50.
97. Dosso M, Bissagnene E, Coulibaly M, et al. Acquired resistance and prescription of antibiotics in Africa: a critical assessment. Med Mal Infect 2000; 30(Suppl 3):197-204.
98. Yoshikawa TT. Antimicrobial resistance and aging: beginning of the end of the antibiotic era? J Am Geriatr Soc 2002; 50:5226-9.
99. Brodsky J, Habib J, Hirschfeld M, Siegel B. Care of the frail elderly in developed and developing countries: the experience and the challenges. Aging Clin Exp Res 2002; 14:279-86.
100. Kunin CM, Lipton HL, Tupasi T, et al. Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4 [review]. Rev Infect Dis 1987; 9(Suppl 3):S270-85.
101. Starling C. Infection control in developing countries. Curr Opin Infect Dis 2001; 14:461-6.
102. Archibald LK, Reller LB. Clinical microbiology in developing countries. Emerg Infect Dis 2001; 7:302-5.
103. Bantar C, Sartori B, Vesco E, et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003; 37:180-6.
104. Quick RE, Kimura A, Thevos A, et al. Diarrhea prevention through household-level water disinfection and safe storage in Zambia. Am J Trop Med Hyg 2002; 66:584-9.
105. Bâ AH. In: Program and abstracts of the United Nations Educational, Scientific, and Cultural Organization (UNESCO) Conference, Geneva, 1962. Geneva: UNESCO, 1962.